Clinical Trials in Ulsan, South Korea
Locations / Ulsan, South Korea
Delta Trials catalogs 452 clinical trials conducted in Ulsan, South Korea, making it a notable site of clinical research activity. These trials spanning 381 distinct medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 30 trials in this location were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations in Ulsan evolve over time.
452
Total Trials
381
Conditions
30
Terminated since 2020
Browse by condition (381 total)
- Coronary artery disease 59 trialsAll Coronary artery disease trials
- Multiple myeloma 20 trialsAll Multiple myeloma trials
- Breast cancer 17 trialsAll Breast cancer trials
- Non-small cell lung cancer 11 trialsAll Non-small cell lung cancer trials
- Carcinoma, non-small-cell lung 8 trialsAll Carcinoma, non-small-cell lung trials
- Type 2 diabetes mellitus 8 trialsAll Type 2 diabetes mellitus trials
- Diabetes mellitus, type 2 8 trialsAll Diabetes mellitus, type 2 trials
- Cardiovascular diseases 7 trialsAll Cardiovascular diseases trials
- Gastric cancer 7 trialsAll Gastric cancer trials
- Diffuse large B-cell lymphoma 7 trialsAll Diffuse large B-cell lymphoma trials
- Leukemia 6 trialsAll Leukemia trials
- Acute myeloid leukemia 6 trialsAll Acute myeloid leukemia trials
- Idiopathic pulmonary fibrosis 6 trialsAll Idiopathic pulmonary fibrosis trials
- Non-Hodgkin lymphoma 5 trialsAll Non-Hodgkin lymphoma trials
- Hemophilia a 5 trialsAll Hemophilia a trials
- Hypertension 5 trialsAll Hypertension trials
- Acute coronary syndrome 5 trialsAll Acute coronary syndrome trials
- Hepatitis b, chronic 5 trialsAll Hepatitis b, chronic trials
- Diabetes 5 trialsAll Diabetes trials
- Coronary disease 5 trialsAll Coronary disease trials